Tolciclate versus miconazole, a double-blind trial in patients with dermatomycosis
| Autor: | L C Cucè, B F Contijo Assunção, A Salibian, L G A Medawar, W Groppi |
|---|---|
| Rok vydání: | 1980 |
| Předmět: |
Adult
Male medicine.medical_specialty Antifungal Agents Miconazole Administration Topical 030204 cardiovascular system & hematology Dermatomycosis Biochemistry Double blind 03 medical and health sciences 0302 clinical medicine Double-Blind Method Tinea Tolciclate Thiocarbamates medicine Dermatomycoses Humans In patient Clinical Trials as Topic Pityriasis business.industry Biochemistry (medical) Imidazoles Tinea Pedis Cell Biology General Medicine medicine.disease Dermatology Outcome and Process Assessment Health Care 030220 oncology & carcinogenesis Tinea capitis Female business medicine.drug |
| Zdroj: | The Journal of international medical research. 8(2) |
| ISSN: | 0300-0605 |
| Popis: | Eighty-one patients with dermatomycosis such as tinea corporis, tinea cruris, tinea pedis and pityriasis versicolor were treated with tolciclate 1% cream or miconazole 2% cream. Parasitological cure was obtained in 100% of the patients given tolciclate and in 97.4% of those given miconazole. Patients and investigator considered tolciclate treatment as excellent, respectively, in 76.2% and 73.8% of the cases. The corresponding figures for miconazole were 74.4% and 66.7%. Both treatments were well tolerated. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|